Your browser doesn't support javascript.
loading
Experimental study of 131I-caerin 1.1 and 131I-c(RGD)2 for internal radiation therapy of esophageal cancer xenografts.
He, Tiantian; Du, Juan; Zhu, Keke; Zhou, Yixuan; Xiao, Zewei; Liu, Wenjie; Ren, Weiwei; Liu, Xiongying; Chen, Tongsheng; Liu, Wenjuan; Chen, Zhuanming; Ni, Guoying; Liu, Xiaosong; Wang, Tianfang; Quan, Jiangtao; Zhang, Peipei; Yuan, Jianwei.
Affiliation
  • He T; Department of Nuclear Medicine, The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
  • Du J; Department of Nuclear Medicine, The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
  • Zhu K; Department of Nuclear Medicine, The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
  • Zhou Y; Department of Nuclear Medicine, The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
  • Xiao Z; Department of Nuclear Medicine, The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
  • Liu W; Department of Nuclear Medicine, The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
  • Ren W; Department of Nuclear Medicine, The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
  • Liu X; Department of Nuclear Medicine, The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
  • Chen T; Department of Nuclear Medicine, The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
  • Liu W; Department of Nuclear Medicine, The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
  • Chen Z; Department of Nuclear Medicine, The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
  • Ni G; Department of Nuclear Medicine, The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
  • Liu X; Department of Nuclear Medicine, The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
  • Wang T; Department of Nuclear Medicine, The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China; Centre for Bioinnovation, University of the Sunshine Coast, Maroochydore BC, QLD 4558, Australia; School of Science, Technology and Engineering, Un
  • Quan J; Department of Radiology, General Hospital of Southern Theater Command, PLA, Guangzhou, Guangdong, China. Electronic address: zyyqjt@163.com.
  • Zhang P; Department of Radiology, The First People's Hospital of Foshan, Foshan, Guangdong, China. Electronic address: zppei209@163.com.
  • Yuan J; Department of Nuclear Medicine, The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China. Electronic address: yjwei214@163.com.
Biomed Pharmacother ; 164: 114891, 2023 Aug.
Article in En | MEDLINE | ID: mdl-37209630
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms Limits: Animals / Humans Language: En Journal: Biomed Pharmacother Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms Limits: Animals / Humans Language: En Journal: Biomed Pharmacother Year: 2023 Document type: Article Affiliation country: Country of publication: